奥马珠单抗治疗慢性荨麻疹：病例系列及文献综述
Omalizumab for chronic urticaria: a case series and overview of the literature.
作者信息
Ivyanskiy Ilya, Sand Carsten, Thomsen Simon Francis
机构信息
Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark.
出版信息
Case Rep Dermatol. 2012 Jan;4(1):19-26. doi: 10.1159/000336205. Epub 2012 Jan 30.
Abstract
Omalizumab is a recombinant humanized monoclonal antibody that blocks the high-affinity Fc receptor of IgE. Omalizumab has been approved for the treatment of moderate to severe asthma; however, there is currently more and more data showing promising results in the management also of chronic urticaria. We present a case series of 19 patients with chronic urticaria treated in a university department with omalizumab and give an overview of the existing literature comprising an additional 59 cases as well as a total of 139 patients enrolled in two randomized controlled trials comparing omalizumab with placebo. The collective evidence points to omalizumab as a safe and effective treatment option for patients with chronic urticaria who do not sufficiently respond to standard therapy as recommended by existing guidelines.
摘要
奥马珠单抗是一种重组人源化单克隆抗体，可阻断IgE的高亲和力Fc受体。奥马珠单抗已被批准用于治疗中重度哮喘；然而，目前越来越多的数据表明，它在慢性荨麻疹的治疗中也显示出了有前景的结果。我们展示了一个在大学科室用奥马珠单抗治疗的19例慢性荨麻疹患者的病例系列，并概述了现有文献，其中包括另外59例病例以及参与两项比较奥马珠单抗与安慰剂的随机对照试验的总共139例患者。综合证据表明，对于那些对现有指南推荐的标准治疗反应不佳的慢性荨麻疹患者，奥马珠单抗是一种安全有效的治疗选择。
相似文献
1
Omalizumab for chronic urticaria: a case series and overview of the literature.奥马珠单抗治疗慢性荨麻疹：病例系列及文献综述
Case Rep Dermatol. 2012 Jan;4(1):19-26. doi: 10.1159/000336205. Epub 2012 Jan 30.
2
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.奥马珠单抗治疗针对甲状腺过氧化物酶的 IgE 的慢性荨麻疹患者的疗效和安全性。
J Allergy Clin Immunol. 2011 Jul;128(1):202-209.e5. doi: 10.1016/j.jaci.2011.04.038. Epub 2011 Jun 2.
3
Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.奥马珠单抗：抗IgE单克隆抗体E25、E25、人源化抗IgE单克隆抗体、IGE 025、单克隆抗体E25、奥立珠单抗、Xolair、重组人源化抗IgE单克隆抗体E25
BioDrugs. 2002;16(5):380-6. doi: 10.2165/00063030-200216050-00009.
4
Omalizumab treatment in a 12 year-old girl with chronic spontaneous urticaria.奥马珠单抗治疗一名12岁慢性自发性荨麻疹女童的病例
J Dermatolog Treat. 2018;29(sup4):10-11. doi: 10.1080/09546634.2018.1551609.
5
Omalizumab in the treatment of chronic urticaria.奥马珠单抗治疗慢性荨麻疹。
Actas Dermosifiliogr. 2014 Jan-Feb;105(1):45-52. doi: 10.1016/j.ad.2013.06.002. Epub 2013 Aug 12.
6
Anti-IgE for the Treatment of Chronic Urticaria.抗IgE用于治疗慢性荨麻疹。
Immunotargets Ther. 2021 Feb 17;10:27-45. doi: 10.2147/ITT.S261416. eCollection 2021.
7
Effects of omalizumab on basophils: Potential biomarkers in asthma and chronic spontaneous urticaria.奥马珠单抗对嗜碱性粒细胞的影响：哮喘和慢性自发性荨麻疹的潜在生物标志物。
Cell Immunol. 2020 Dec;358:104215. doi: 10.1016/j.cellimm.2020.104215. Epub 2020 Sep 12.
8
Omalizumab is efficacious for management of recalcitrant, antihistamine-resistant chronic urticaria.奥马珠单抗对顽固性、抗组胺药难治性慢性荨麻疹的治疗有效。
Drugs Today (Barc). 2015 Jun;51(6):367-74. doi: 10.1358/dot.2015.51.6.2333219.
9
Ligelizumab for Chronic Spontaneous Urticaria.利格司亭治疗慢性自发性荨麻疹。
N Engl J Med. 2019 Oct 3;381(14):1321-1332. doi: 10.1056/NEJMoa1900408.
10
Anti-IgE: A treatment option in allergic rhinitis?抗IgE：过敏性鼻炎的一种治疗选择？
Allergol Select. 2021 Feb 24;5:119-127. doi: 10.5414/ALX02205E. eCollection 2021.
引用本文的文献
1
Prevalence, Clinical Manifestations, Treatment, and Clinical Course of Chronic Urticaria in Elderly: A Systematic Review.老年人慢性荨麻疹的患病率、临床表现、治疗及临床病程：一项系统评价
J Asthma Allergy. 2022 Oct 20;15:1455-1490. doi: 10.2147/JAA.S379912. eCollection 2022.
2
The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 2. Management of H1-Antihistamine-Refractory Chronic Urticaria.韩国成人及儿童慢性自发性荨麻疹的KAAACI/KDA循证实践指南：第2部分。H1抗组胺药难治性慢性荨麻疹的管理。
Allergy Asthma Immunol Res. 2020 Sep;12(5):750-770. doi: 10.4168/aair.2020.12.5.750.
3
Does omalizumab treatment affect serum dehydroepiandrosterone sulphate levels in chronic idiopathic urticaria?奥马珠单抗治疗对慢性特发性荨麻疹患者血清硫酸脱氢表雄酮水平有影响吗？
Postepy Dermatol Alergol. 2019 Feb;36(1):92-97. doi: 10.5114/ada.2018.75328. Epub 2019 Feb 22.
4
Consensus Statement for the Diagnosis and Treatment of Urticaria: A 2017 Update.《荨麻疹诊断和治疗的共识声明：2017年更新版》
Indian J Dermatol. 2018 Jan-Feb;63(1):2-15. doi: 10.4103/ijd.IJD_308_17.
5
Treatment of Chronic Spontaneous Urticaria with a Single Dose of Omalizumab: A Study of Four Cases.单剂量奥马珠单抗治疗慢性自发性荨麻疹：4例病例研究
Indian J Dermatol. 2016 Jul-Aug;61(4):467. doi: 10.4103/0019-5154.185745.
6
Cutaneous and gastrointestinal symptoms in two patients with systemic mastocytosis successfully treated with omalizumab.两名系统性肥大细胞增多症患者经奥马珠单抗成功治疗后的皮肤和胃肠道症状
Case Rep Med. 2015;2015:903541. doi: 10.1155/2015/903541. Epub 2015 Jan 28.
7
Management of urticaria: not too complicated, not too simple.荨麻疹的管理：既不太复杂，也不太简单。
Clin Exp Allergy. 2015 Apr;45(4):731-43. doi: 10.1111/cea.12465.
8
Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases.奥马珠单抗长期治疗难治性重度慢性荨麻疹：两例分析
Postepy Dermatol Alergol. 2014 Oct;31(5):332-4. doi: 10.5114/pdia.2014.44023. Epub 2014 Oct 22.
9
The bee sting that was not: an unusual case of hymenoptera anaphylaxis averted in a patient treated with omalizumab for asthma.并非蜜蜂蜇伤：一例接受奥马珠单抗治疗哮喘的患者成功避免膜翅目昆虫过敏反应的罕见病例。
Case Rep Med. 2014;2014:138963. doi: 10.1155/2014/138963. Epub 2014 Aug 12.
10
A case series study of eighty-five chronic spontaneous urticaria patients referred to a tertiary care center.一项针对八十五名转诊至三级护理中心的慢性自发性荨麻疹患者的病例系列研究。
Ann Dermatol. 2014 Feb;26(1):73-8. doi: 10.5021/ad.2014.26.1.73. Epub 2014 Feb 17.
本文引用的文献
1
Failure of omalizumab (Xolair®) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light.奥马珠单抗（茁乐®）治疗由紫外线 A 和可见光引起的光线性荨麻疹失败。
Photodermatol Photoimmunol Photomed. 2011 Dec;27(6):336-7. doi: 10.1111/j.1600-0781.2011.00624.x.
2
Omalizumab in allergic diseases, a recent review.奥马珠单抗在过敏性疾病中的应用：综述。
Asian Pac J Allergy Immunol. 2011 Sep;29(3):209-19.
3
Omalizumab in treatment-resistant chronic spontaneous urticaria.奥马珠单抗治疗难治性慢性自发性荨麻疹
Indian J Dermatol. 2011 Jul;56(4):444. doi: 10.4103/0019-5154.84737.
4
T cell activity in successful treatment of chronic urticaria with omalizumab.奥马珠单抗成功治疗慢性荨麻疹中的T细胞活性
Clin Mol Allergy. 2011 Jul 26;9:11. doi: 10.1186/1476-7961-9-11.
5
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.一项奥马珠单抗单剂量、安慰剂对照、剂量范围研究，用于 H1 抗组胺药难治性慢性特发性荨麻疹患者。
J Allergy Clin Immunol. 2011 Sep;128(3):567-73.e1. doi: 10.1016/j.jaci.2011.06.010. Epub 2011 Jul 18.
6
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.奥马珠单抗治疗针对甲状腺过氧化物酶的 IgE 的慢性荨麻疹患者的疗效和安全性。
J Allergy Clin Immunol. 2011 Jul;128(1):202-209.e5. doi: 10.1016/j.jaci.2011.04.038. Epub 2011 Jun 2.
7
Omalizumab is effective in nonautoimmune urticaria.奥马珠单抗对非自身免疫性荨麻疹有效。
J Allergy Clin Immunol. 2011 May;127(5):1300-2. doi: 10.1016/j.jaci.2010.12.1085. Epub 2011 Feb 11.
8
Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab.高亲和力IgE受体的下调与奥马珠单抗成功治疗慢性特发性荨麻疹相关。
Clin Mol Allergy. 2011 Jan 19;9(1):2. doi: 10.1186/1476-7961-9-2.
9
Omalizumab--an effective and safe treatment of therapy-resistant chronic spontaneous urticaria.奥马珠单抗——治疗难治性慢性自发性荨麻疹的一种有效且安全的疗法。
Allergy. 2011 Feb;66(2):303-5. doi: 10.1111/j.1398-9995.2010.02472.x. Epub 2010 Sep 7.
10
Omalizumab therapy in three patients with chronic autoimmune urticaria.三名慢性自身免疫性荨麻疹患者的奥马珠单抗治疗
Ann Saudi Med. 2010 Nov-Dec;30(6):478-81. doi: 10.4103/0256-4947.70567.
Zotero 插件